Transactions
Showing 622-630 of 969 items
-
C$150m
Hydropothecary
Co-Bookrunner (Public Offering)
-
C$23m
Delta 9 Cannabis
Lead (Bought Deal)
-
C$58m
OrganiGram
Co-Manager (Equity Financing)
-
C$11m
Khiron Life Sciences Corp
Lead (RTO Financing)
-
US$300m
Blueprint Medicines
Co-Manager (Follow-on)
-
C$16m
Sante Veritas Therapeutics
Co-Lead (Private Placement)
-
C$5m
LexaGene Holdings
Sole Bookrunner (Equity Follow-on)
-
N/a
Health Connect America
Financial Advisor on sale to Harren Equity Partners
-
N/a
Galena Biopharma
Financial Advisor to Galena Biopharma on its merger with SELLAS Life Sciences Group, Inc.
